reference/23521474

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23521474

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	3998
issn	1527-7755 0732-183X
issueIdentifier	30
pageRange	3990-3998
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3990
bibliographicCitation	Watanabe T, Tobinai K, Shibata T, Tsukasaki K, Morishima Y, Maseki N, Kinoshita T, Suzuki T, Yamaguchi M, Ando K, Ogura M, Taniwaki M, Uike N, Takeuchi K, Nawano S, Terauchi T, Hotta T. Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trial. J Clin Oncol. 2011 Oct 20;29(30):3990–8. doi: 10.1200/jco.2011.34.8508. PMID: 21931035.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da2f3876fcc309dadc3a2b8280896951 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66e7cc8693a50fddd6767f790c2e19d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e30d0e7dd298723742d1fdf9e9fa21b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_680655463fba1bc032dd738a903cab45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab8a7fbf37306725b0885abf201d69f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbe53d293838c0d357cee0791e0a916d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38955c389d1f94329b5e69441a5c8f41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51153bcbdbb56550b620bf4ad069f316 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce6db8ef14a9cb66794dcfa2ecdd4f6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b9d142123034e5cfa979c466cfaaabf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddf0fb11d68578adb6e2dfe057c01786 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_212e3c515ee9c3f02258bd8c4339f9bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_695f0309fe0c11c125a8732a2cd61156 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1599-5800 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af4851e1bc03db8abee231f7b26e7a73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba20ae96d2d01f8d3245a5f069ed2e94 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f4924893bf2a62b8c3b3f25b115819c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27b4a5eb97c0c421d656442a680365ea
date	2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21931035 https://doi.org/10.1200/jco.2011.34.8508
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial
discusses	http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0024696 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0022676
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016393Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D011241Q000009 http://id.nlm.nih.gov/mesh/D016393Q000473 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D014750Q000009 http://id.nlm.nih.gov/mesh/D058846Q000009 http://id.nlm.nih.gov/mesh/D058846Q000008 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003520Q000009 http://id.nlm.nih.gov/mesh/D004317Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D016179Q000008 http://id.nlm.nih.gov/mesh/D015996
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9856 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f762fe2442e70fe54d540f3fd4225b55 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 87.